142 related articles for article (PubMed ID: 34848179)
1. Intrauterine device, subdermal contraceptive, and depot medroxyprogesterone use among transmasculine and cisgender patients over a 10-year period.
Berglin M; Stram D; Stenquist A; Dessi S; Ritterman Weintraub M; Zaritsky E
Contraception; 2022 Apr; 108():56-60. PubMed ID: 34848179
[TBL] [Abstract][Full Text] [Related]
2. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
3. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
Paul R; Huysman BC; Maddipati R; Madden T
Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
[TBL] [Abstract][Full Text] [Related]
4. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
5. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
6. Impact of contraceptive initiation on vaginal microbiota.
Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
[TBL] [Abstract][Full Text] [Related]
7. An exploratory analysis of contraceptive method choice and symptoms of depression in adolescent females initiating prescription contraception.
Francis J; Presser L; Malbon K; Braun-Courville D; Linares LO
Contraception; 2015 Apr; 91(4):336-43. PubMed ID: 25553873
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
Usinger KM; Gola SB; Weis M; Smaldone A
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
[TBL] [Abstract][Full Text] [Related]
9. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
10. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
Varney SJ; Guest JF
Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
[TBL] [Abstract][Full Text] [Related]
11. Changing US trends in contraceptive choices.
Vegunta S; Carrubba AR; Wasson MN
Cleve Clin J Med; 2021 Dec; 88(12):689-695. PubMed ID: 34857607
[TBL] [Abstract][Full Text] [Related]
12. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
[TBL] [Abstract][Full Text] [Related]
13. Postpartum contraceptive use among adolescent mothers.
Templeman CL; Cook V; Goldsmith LJ; Powell J; Hertweck SP
Obstet Gynecol; 2000 May; 95(5):770-6. PubMed ID: 10775745
[TBL] [Abstract][Full Text] [Related]
14. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
Cremer M; Ditzian L; April A; Peralta E; Klausner D; Podolsky R; Dierking E
J Womens Health (Larchmt); 2011 Nov; 20(11):1751-6. PubMed ID: 21823919
[TBL] [Abstract][Full Text] [Related]
15. Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception.
Guirguis-Blake J
Am Fam Physician; 2011 Jan; 83(1):35-6. PubMed ID: 21888124
[No Abstract] [Full Text] [Related]
16. Selection, Initiation, Continuation, and Efficacy of Reversible Contraception Among Enlisted U.S. Service Women in Their First Term of Service From 2012 to 2020.
Roberts CM; Smalley JM; Adelman WP; Weir LF; Hisle-Gorman E
Mil Med; 2024 Jan; 189(1-2):e227-e234. PubMed ID: 37542725
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
18. Long-acting contraceptives in adolescents.
Tolaymat LL; Kaunitz AM
Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
20. Contraception across the transmasculine spectrum.
Krempasky C; Harris M; Abern L; Grimstad F
Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
